Skip to content

Effectiveness of Online Mindfulness Platform in Improving Anxiety, Depression, and Stress in Adults During the COVID-19 Pandemic: A Randomized Control Trial.

Tso-Ying Lee, Cha-Jung Hsieh, Pi-Hsia Lee

Studies in health technology and informatics July 24, 2024 DOI: 10.3233/SHTI240179 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Population Adult patients from a regional hospital
Intervention online mindfulness intervention
Duration 8-week intervention
Topics Anxiety Depression Meditation
Keywords Covid-19 pandemic Adults Online mindfulness platform Stress
Key findings Online mindfulness intervention significantly reduced anxiety scores compared to general health education at four and eight weeks, but stress and depression did not differ between groups.

Abstract

COVID-19 epidemic bring a great threat to human physical and mental health. This study aimed to investigate the effectiveness of an online mindfulness platform in improving mental status. Patients from a regional hospital were randomly divided into the experimental and control groups. The experimental group received online mindfulness interventions, and control group received general health education. There were no significant differences in the stress or depression scores between the two groups (P > 0.05). Intervention group had significantly lower anxiety scores than control group at fourth and eighth weeks (P 0.05). The anxiety in the intervention group was significantly improved at the 4th and 8th weeks (P<0.05). Moreover, the stress and depression in the intervention group were significantly improved at the 8th week (P<0.05). Online mindfulness intervention can effectively improve emotional status.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics